Did Celltex just get an FDA warning letter? I’m not sure. We may find out tomorrow as the FDA updates their public warning letter list early in the week. What’s Celltex? Celltex is that famous stem cell company in Sugarland, Texas that gave Guv Rick Perry stem cell transplants. It was inspected by the FDA […]
Did Celltex just get an FDA warning letter? Read More »
Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding from investment company, Lincoln Park Capital. The press release quotes CEO Gary Rabin: “We are most pleased about this financing agreement, as it has a number of notable benefits for the company,” commented Gary Rabin, chairman and CEO of
Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million Read More »
I love stem cells, but I have to admit bionics is totally amazing as well. Both hold great promise for fixing up human beings as we injured or age. Today a major advance in vision correction via bionics was announced here at UC Davis that has really caught my attention. I was not involved in
Bionic eye here at UC Davis holds great promise for restoring vision Read More »
Of course stem cells and their caretakers never sleep or take the weekend off, right? But still TGIF! Last week we had some really good and some ugly stem cell headlines that I covered here. How was this week? Good. ES cell differentiation requires chromatin compaction. A PLoS Genetics paper by a team led by Yuhong
TGIF: headlines on stem cells for May 11 Read More »
It wasn’t so long ago that I did a post explaining why after following the company for years, I finally bought a small amount of stock in the stem cell biotech, Advanced Cell Technology (ACT; symbol ACTC). In part it was motivated by my enthusiasm to see them publishing a paper, a very preliminary paper,
Why Lanza and I sold ACT stock Read More »
What’s up with Advanced Cell Technology (ACT) and Geron? ACT announced today that it has treated two patients in its clinical trials: one for Stargardt’s Macular Dystrophy (see official trial page for a lot more info) and one for Dry Age-Related Macular Degeneration (see official trial page here for a lot more info). The patients underwent
The latest scoop on ACT and Geron Read More »
Two companies, Advanced Cell Technology (ACT) and Geron, both HQ’d here in California, have FDA-approved early stage clinical trials in the works. Geron’s trial has already started and reportedly now has enrolled at least two patients. The trial is of course for the safety of Geron’s GRNOPC1 oligodendrocyte product made from human ES cells for
Advanced Cell Technology and Geron: allies or competitors? Read More »
In this post I give my most interesting predictions about events in the stem cell field in 2011. Update: I’ve continuing doing predictions every year all the way through 2020 and intend to continue. See my 2012-2020 predictions here. Appeals court rules in favor of federally funded hESC research. This is more of a hope
Predictions for Stem Cells in 2011 Read More »
Advanced Cell Technology (ACT) announced that the FDA has approved their second human ES cell-based clinical trial, a combined Phase I/II, for the treatment of blindness. Advanced Cell Technology As a result, soon ACT will have two active, human ES cell-based clinical trials, both using the same human ES cell-based drug. The aim of the
FDA approves Advanced Cell Technology second stem cell trial for blindness Read More »
Even as some unproven, for-profit stem cell clinics promote themselves aggressively in many ways including now on TV, on the flip side lately we’ve seen more TV journalists covering questionable marketing by the clinics and negative patient outcomes. Today I saw that CBS This Morning, a national broadcast, had a fairly long TV segment on stem
TV Journalists Tackling Stem Cell Clinics Read More »